EPOR and prostate adenocarcinoma: Interestingly, a statistically significant (P<0.05) decrease in levels of EPOR transcripts in kidney tumours, lung squamous cell carcinoma, lymphomas, and prostate adenocarcinoma relative to normal tissues was identified (Figure 4).